Head of Scientific Advisory Board
Dr Zohar Koren, Ph.D, MBA Co-founded Cannabics Inc., in 2012 and serves as its Chief Executive Officer and Director. Dr. Koren served as the Chief Executive Officer of Cannabics Pharmaceuticals Inc. (formerly, American Mining Corporation) from April 29, 2014 to January 2015. Dr. Koren served as Director of Business Development of Aposense, a publicly traded pharmaceutical development company. Prior to that, he served as Business Development Manager at Harel-Hertz, where he led the Life Sciences Department of Business Development in Japan. Dr. Koren has also provided strategic consulting services for several leading Israeli venture capital firms specific to the pharmaceutical and medical device arena. Dr. Koren served as a Director of Cannabics Pharmaceuticals Inc. from April 29, 2014 to January 2015. Dr. Koren holds a Ph.D. in Computational Biology and an M.Sc. in Evolutionary and Environmental Sciences, both Magna Cum Laude, from the University of Haifa and a B.Sc. in Mathematics, Physics and Biology from the Hebrew University in Jerusalem.